Fannin
is a life science development firm that develops and operates early-stage therapeutic and medical device technologies... Read moreFannin
is a life science development firm that develops and operates early-stage therapeutic and medical device technologies... Read more
News
Jan 09, 2026
PR Newswire
Press Release: Fannin : Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD
Jan 09, 2026
PR Newswire
Press Release: Fannin : Immunology Drug Development Veteran Brian Wipke Joins Fannin Partners and Allterum Therapeutics
Nov 11, 2025
PR Newswire
Press Release: Fannin : Advancing Hope for Children with Leukemia: Allterum Therapeutics Receives FDA Fast Track Designation for 4A10 in Acute Lymphoblastic Leukemia
Oct 10, 2024
StreetInsider
Press Release: Fannin : Fannin Partners Secures Grant Funding from NIDA and DoD to Advance Novel PDE4B Inhibitors for Neurological Diseases
Sep 19, 2024
OINDPnews
Fannin: Pulmotect raises $5.9 million in Series C funding to support Phase 2 trial of PUL-042 inhalation solution in cancer patients
Sep 17, 2024
EIN Presswire
Press Release: Fannin : Pulmotect Raises $5.9M Series C Round Led by Fannin Partners
May 29, 2024
PRWeb
Press Release: Fannin : Fannin launches Radiomer Therapeutics with novel targeting vector/ligand platform for radiopharmaceuticals
Apr 11, 2024
Medical Product Outsourcing
Fannin: Procyrion Closes $57.7 Million in Series E Financing
Feb 23, 2024
Global Legal Chronicle
Fannin: Procyrion's $57.7 Million Series E Financing Round
Feb 05, 2024
FinSMEs
Fannin: Procyrion Closes $57.7M in Series E Funding
Fannin Competitors
1
2
3
4
5
6
7
8